Gland Pharma Limited (BOM:543245)
India · Delayed Price · Currency is INR 2,200.95
+3.80 (0.17%)
At close: Jun 18, 2026
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 362.3 billion as of June 18, 2026. Its market cap has increased by 38.42% in one year.
Market Cap
362.30B
Enterprise Value
330.81B
Revenue
64.31B
Ranking
n/a
PE Ratio
35.27
Stock Price
2,200.95
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 362.30B, an increase of 21.94%. That is a compound annual growth rate of 3.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 362.30B | 27.70% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.08T |
| Dr. Reddy's Laboratories | 1.06T |
| Abbott India | 557.17B |
| GlaxoSmithKline Pharmaceuticals | 395.20B |
| J. B. Chemicals & Pharmaceuticals | 351.51B |
| Rubicon Research | 224.36B |
| AstraZeneca Pharma India | 210.17B |
| Granules India | 194.73B |